Dublin, Aug. 23, 2021 (GLOBE NEWSWIRE) -- The "Drug-Eluting Stents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Drug-Eluting Stents Market to Reach $7.5 Billion by 2027
Amid the COVID-19 crisis, the global market for Drug-Eluting Stents estimated at US$5.7 Billion in the year 2020, is projected to reach a revised size of US$7.5 Billion by 2027, growing at a CAGR of 4% over the period 2020-2027.
Polymer-Free, one of the segments analyzed in the report, is projected to record 4.3% CAGR and reach US$5.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymer-based segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 7.2% CAGR
The Drug-Eluting Stents market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.2% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Coronary Stents Market - A Prelude
- Recent Market Activity
- Competitive Scenario
- J&J Exit from DES Market Improves Prospects for Competitors
- Evolution of the Drug-Eluting Stent
- Evolution of Drug-Eluting Stents (DES) Over the Years
- Comparative Analysis of Drug-Eluting Stents in Terms of Physical Parameters
- Bioabsorbable Stents
- New Stents with Biodegradable Polymers
- Completely Bioresorbable Scaffolds: Potential Game-Changer
- Noteworthy Clinical Studies and Innovations
- Study Proves Efficacy of Very Thin Strut DES On Par with Durable Polymer Stents
- Drug-Eluting Stents and Drug-Coated Balloons for Non-Coronary Indications
- DES for Large Sized Arteries
- Addressing the Unmet Challenges in Patients with Diabetes
- Biosensors Commercializes BMX-J DES System
- SLENDER DES Set to Downsize the Future of Interventional Cardiology
- Other Novel DES Launches
- Researchers at University of Strathclyde Evaluate VAN 10-4 Small Molecule
- DES Safe for Vein Grafts Procedures
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- Abbott Laboratories (US)
- AlviMedica (Turkey)
- Arterius Limited (UK)
- B. Braun Melsungen AG (Germany)
- Biosensors International Group, Ltd. (Singapore)
- Shandong JW Medical Systems LTD. (China)
- Biotronik SE & Co. KG (Germany)
- Boston Scientific Corporation (US)
- Cook Medical Inc. (US)
- Elixir Medical Corp. (US)
- KYOTO MEDICAL PLANNING Co., Ltd. (Japan)
- Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Medtronic plc (Republic of Ireland)
- Micell Technologies, Inc. (US)
- Opto Circuits (India) Ltd (India)
- Eurocor GmbH (Germany)
- OrbusNeich Medical Company Limited (Hong Kong)
- QualiMed (Germany)
- Shanghai MicroPort Medical (Group) Co., Ltd. (China)
- Sino Medical Sciences Technology Inc. (China)
- STENTYS SA (France)
- Terumo Corporation (Japan)
3. MARKET TRENDS & DRIVERS
- Key Market Drivers & Restraints
- Aging - A Key Market Driver
- Global Aging Population Demographic Statistics: Key Opportunity Indicator
- High Diabetes Incidence Worldwide Drives Demand for Cardiac Surgery and Stents
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
- United States
- Canada
- Japan
- China
- Europe
- France
- Germany
- Italy
- United Kingdom
- Spain
- Russia
- Rest Of Europe
- Asia-Pacific
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest Of Latin America
- Middle East
- Iran
- Israel
- Saudi Arabia
- United Arab Emirates
- Rest Of Middle East
- Africa
IV. COMPETITION
- Total Companies Profiled: 35
For more information about this report visit https://www.researchandmarkets.com/r/xc28x
